News

Filter

Current filters:

IpsenIncrelex

1 to 9 of 13 results

Ipsen expects Increlex supply interruption; 1st-qtr sales up 5.3%

25-04-2013

French drugmaker Ipsen (Euronext: IPN) says that its supplier of Increlex (mecasermin [rDNA origin] Injection)…

FinancialIncrelexIpsenLonzaPharmaceuticalProduction

France’s Ipsen sees strong 3rd quarter and nine month 2009 performance

29-10-2009

French biopharmaceutical company Ipsen reported a 5.8% rise in sales in the first nine months of 2009,…

Abobotulinumtoxin A InjectionApokynApomorphineDysportFinancialIncrelexIpsenMecasermin [rDNA origin] InjectionPharmaceutical

Ipsen/Tercica's Increlex approved in Europe

20-08-2007

French drugmaker Ipsen says that the European Commission has granted marketing authorization for Increlex…

Antihemophilic FactorCoagulation Factor VIIaHumulin 70-30Humulin NHumulin RIncrelexInsulinIpsenMecasermin [rDNA origin] InjectionRecombinant

1 to 9 of 13 results

COMPANY SPOTLIGHT

Menarini

Back to top